Drugs / AZD6088
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00931541 | Jun → Aug 2009 | — | AstraZeneca | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AZD6088 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00931541 ↗ |
| Modality | Small molecule | — CHEMBL5095221 ↗ |
| Route | Oral | “AZD6088 oral solution” NCT00931541 ↗ |